Background-We have previously described the experience, rationale, and deve
lopment of a valve preserving technique, but its role in patients with Marf
an syndrome has not previously been defined. Here, we attempt to determine
the early and long-term results, timing, and determinants of outcome of thi
s operation in patients with Marfan syndrome.
Methods and Results-Since 1979, 82 patients (73.2% of all patients with Mar
fan syndrome undergoing resection of aneurysm of the ascending aorta) were
operated on using this technique. Ages ranged from 2 to 69 years (mean, 33.
9 years). In all, there were 4 early deaths (4.9%), 2 with acute dissection
and 2 with chronic aneurysm operated on as emergencies. There were no earl
y deaths in 67 patients operated on electively. Actuarial survival for pati
ents operated for chronic aneurysm was 94.2%, 94.2%, and 94.2% at 1, 5, and
10 years, respectively; that for acute dissection was 72.7%, 63.6%, and 63
.6%; and that for chronic dissection was 100%, 85.7%, and 75.0%. The probab
ility of needing reoperation was 5.7%, 17.3%, and 17.3% at 1, 5, and 10 yea
rs. There were no instances of infective endocarditis or thromboembolic com
plications except in 2 patients operated on early in the series who had cus
p extension. At the end of the follow-up, trivial or no aortic regurgitatio
n was demonstrated in 33.3%, mild in 45.6%, moderate in 21.1%, and severe i
n 0.
Conclusions-Valve-sparing operations are feasible in most patients with Mar
fan syndrome; they are applicable to patients with both dissection and chro
nic aneurysm. The early and long-term results are encouraging. Results are
better in the absence of dissection, and prophylactic operation is warrante
d in some cases.